TY - JOUR
T1 - Time to Endovascular Reperfusion and Outcome in Acute Ischemic Stroke
T2 - A Nationwide Prospective Registry in China
AU - ANGEL-ACT study group
AU - Ma, Gaoting
AU - Yu, Zequan
AU - Jia, Baixue
AU - Xian, Ying
AU - Ren, Zeguang
AU - Mo, Dapeng
AU - Ma, Ning
AU - Gao, Feng
AU - Tong, Xu
AU - Shi, Xiangqun
AU - Li, Ling
AU - Pan, Yuesong
AU - Miao, Zhongrong
N1 - Funding Information:
ZM designed, led the study and had full access to all of the data in the study and took responsibility for the integrity of the data and the accuracy of the data analysis. GM and YP prepared the first draft of the report. YP did statistical analyses. All authors except YX, LL, YP, and ZR participated in patient enrolment, collection of data. All authors critically reviewed the report and approved the final version. We thank all the 111 participating centers for enrolling patients and the AINR-CoreLab for imaging analysis. This study is supported by grants from the National Key R&D Program of China (2016 YFC1301500), National Natural Science Foundation of China (81971091), Beijing Hospitals Authority Youth Programme (QML20190501).
Funding Information:
This study is supported by grants from the National Key R&D Program of China (2016 YFC1301500), National Natural Science Foundation of China (81971091), Beijing Hospitals Authority Youth Programme (QML20190501).
Publisher Copyright:
© 2022, The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.
PY - 2022/12
Y1 - 2022/12
N2 - Purpose: The benefit of endovascular reperfusion therapy for acute ischemic stroke is highly time-dependent but the relation of delays in workflow with outcomes and the key determinants of delays remain uncertain. This study aimed to evaluate the association between faster endovascular therapy and outcomes in a Chinese population with acute ischemic stroke. Methods: Patients treated with endovascular therapy within 7 h due to anterior large vessel occlusion were enrolled in the ANGEL-ACT registry. Time intervals from hospital arrival to arterial puncture (door-to-puncture), hospital arrival to reperfusion (door-to-reperfusion) and puncture-to-reperfusion were recorded. The outcomes included modified Rankin Scale (mRS) scores 0–1, 0–2, mortality at 3 months, substantial reperfusion, and symptomatic intracranial hemorrhage (sICH). Results: Of 932 patients receiving endovascular therapy (mean age 65.1 years, 60.1% male), the median door-to-puncture, door-to-reperfusion, and puncture-to-perfusion times were 110min (interquartile range, IQR 72–155min), 200min (IQR, 149–260min), and 76min (IQR, 50–118min). Of the patients 87.4% achieved substantial reperfusion and 9.6% had sICH. The mRS 0–1, 0–2, and mortality at 3 months were 39.8%, 43.2%, and 16.4%. Faster door-to-reperfusion and puncture-to-reperfusion were associated with higher likelihood of mRS 0–1, mRS 0–2, and lower rate of sICH. There was a trend of improved mRS, lower mortality, and fewer ICH with shorter door-to-puncture time; however, most differences were not statistically significant. Conclusion: Among patients with acute ischemic stroke in routine clinical practice, shorter time to reperfusion was associated with better outcome after endovascular therapy. Standardized workflows and training in endovascular treatment techniques should be promoted nationally to reduce in-hospital delays.
AB - Purpose: The benefit of endovascular reperfusion therapy for acute ischemic stroke is highly time-dependent but the relation of delays in workflow with outcomes and the key determinants of delays remain uncertain. This study aimed to evaluate the association between faster endovascular therapy and outcomes in a Chinese population with acute ischemic stroke. Methods: Patients treated with endovascular therapy within 7 h due to anterior large vessel occlusion were enrolled in the ANGEL-ACT registry. Time intervals from hospital arrival to arterial puncture (door-to-puncture), hospital arrival to reperfusion (door-to-reperfusion) and puncture-to-reperfusion were recorded. The outcomes included modified Rankin Scale (mRS) scores 0–1, 0–2, mortality at 3 months, substantial reperfusion, and symptomatic intracranial hemorrhage (sICH). Results: Of 932 patients receiving endovascular therapy (mean age 65.1 years, 60.1% male), the median door-to-puncture, door-to-reperfusion, and puncture-to-perfusion times were 110min (interquartile range, IQR 72–155min), 200min (IQR, 149–260min), and 76min (IQR, 50–118min). Of the patients 87.4% achieved substantial reperfusion and 9.6% had sICH. The mRS 0–1, 0–2, and mortality at 3 months were 39.8%, 43.2%, and 16.4%. Faster door-to-reperfusion and puncture-to-reperfusion were associated with higher likelihood of mRS 0–1, mRS 0–2, and lower rate of sICH. There was a trend of improved mRS, lower mortality, and fewer ICH with shorter door-to-puncture time; however, most differences were not statistically significant. Conclusion: Among patients with acute ischemic stroke in routine clinical practice, shorter time to reperfusion was associated with better outcome after endovascular therapy. Standardized workflows and training in endovascular treatment techniques should be promoted nationally to reduce in-hospital delays.
KW - Artery
KW - Stroke
KW - Thrombectomy
KW - Training
KW - Workflow
UR - http://www.scopus.com/inward/record.url?scp=85132249305&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85132249305&partnerID=8YFLogxK
U2 - 10.1007/s00062-022-01178-7
DO - 10.1007/s00062-022-01178-7
M3 - Article
C2 - 35622100
AN - SCOPUS:85132249305
SN - 1869-1439
VL - 32
SP - 997
EP - 1009
JO - Clinical Neuroradiology
JF - Clinical Neuroradiology
IS - 4
ER -